CAJ | 학술논문

目的：分析脊髓型颈椎病患者前路间盘切除减压植骨融合术的预后因素。方法收集2000年12月~2003年8月中国医科大学附属盛京医院87例行颈椎前路间盘切除减压植骨融合术的脊髓型颈椎病患者,按照颈椎病脊髓功能改善情况分为改善率≥75%组和改善率<75%组,利用单因素分析和多因素分析方法评价年龄、性别、职业、教育程度、吸烟史、术前肢体疼痛强度及频率、病程、DRAM评分、JOA评分、止痛药使用情况等因素与颈椎病预后的关系。结果单因素分析发现年龄、吸烟史、术前肢体疼痛强度、病程、DRAM评分、JOA评分与疾病的预后有关(P<0.05),多元线性回归分析发现吸烟史,颈痛、上肢痛,JOA评分与治疗结局密切相关。结论无吸烟嗜好、术前JOA评分较高以及颈痛和上肢痛强度低均提示较好的预后,但需重视DRAM评分对脊髓型颈椎病减压手术预后的影响。
목적：분석척수형경추병환자전로간반절제감압식골융합술적예후인소。방법수집2000년12월~2003년8월중국의과대학부속성경의원87례행경추전로간반절제감압식골융합술적척수형경추병환자,안조경추병척수공능개선정황분위개선솔≥75%조화개선솔<75%조,이용단인소분석화다인소분석방법평개년령、성별、직업、교육정도、흡연사、술전지체동통강도급빈솔、병정、DRAM평분、JOA평분、지통약사용정황등인소여경추병예후적관계。결과단인소분석발현년령、흡연사、술전지체동통강도、병정、DRAM평분、JOA평분여질병적예후유관(P<0.05),다원선성회귀분석발현흡연사,경통、상지통,JOA평분여치료결국밀절상관。결론무흡연기호、술전JOA평분교고이급경통화상지통강도저균제시교호적예후,단수중시DRAM평분대척수형경추병감압수술예후적영향。
Objective To detect the factors that affect the prognosis of anterior cervical decompression and fusion for cervical spondylotic myelopathy. Methods From December 2000 to August 2003, in Shengjing Hospital of China Med-ical University, 87 patients with cervical spondylotic myelopathy after anterior cervical decompression and fusion oper-ation were collected and divided into improvement rate≥ 75%group and improvement rate <75%group, according to the function improvement of the cervical spinal cord disease. using of monofactorial analysis and multiple linear regres-sion, the association between prognosis and age, sex, occupation, educational level, smoking, strength and frequency of preoperative limb pain, course of disease, DRAM score, JOA score, use of analgetica and so on were analyzed. Results Monofactorial analysis showed that age, smoking, strength of preoperational limb pain, course of disease, DRAM score and JOA score related to prognosis (P<0.05). Multiple linear regression suggested that smoking, strength of preopera-tive limb pain and JOA score had significant correlation with the prognosis. Conclusion Non-smoking, lower preopera-tive pain level of neck and upper limb, and higher JOA scores predict better prognosis, the contribution of DRAM score to the prognosis of cervical spondylotic myelopathy should not be ignored at the same time.